PredicTx - Empowering Clinicians with AI-Powered Chemotherapy Dosing

We envision a world where oncology treatment is personalised

and precise, reducing toxicity

and

improving patient outcomes.

We aim to make PredicTx the global standard in oncology treatment.

0
1
2
3
4
5
6
7
8
9
0

Globally new cancer
cases each year

0
1
2
3
4
5
6
7
8
9
0

Cancer patients requiring
chemotherapy each year

The Problem

Current chemotherapy dosing is outdated in precision era

PredicTx is an Australian pioneering solution in cancer chemotherapy dosing, offering groundbreaking accuracy, and tailored personalised cancer care. As first movers in this novel field, we are proud to be at the forefront of cancer treatment.

The Solution

PredicTx Capabilities

Addressing critical oncology dosing challenges.

Chemotherapy
Dosing

Personalised dosing using CT-based body composition for cancer treatment.

Bone
Health

3D bone quality mapping offers a cost-effective alternative to DEXA scans.

Muscle
Analysis

3D muscle mapping aids in sarcopenia risk assessment, prehabilition and rehabilitation planning.

Your Cancer Cure,
Our Priority

PredicTx is committed to support clinicians provide world class, patient tailored chemotherapy treatment. Our goal is to help as many cancer patients complete their chemotherapy treatment successfully.

Empowering Clinicians with

AI-Powered

Chemotherapy Dosing